Our Focus – Why Female Cancers
Female cancers merit dedicated solutions.
Women struggling with cancer need more breakthroughs. It’s time for a new approach.
The Problem
Despite significant need, no approved radiopharmaceuticals currently address cancers that predominantly affect women.
Current therapies often overlook female biology — leaving female cancers at a disadvantage and not fully use the potential of these modern treatments.
Why It Matters
When we don’t prioritise women’s health, we neglect society. Investing in cures for female cancers strengthens families, communities, and futures.
GAIASO’s View
We’re transforming a field — starting with the most underserved, hardest-to-treat female cancers.
Target Indications
-
Breast cancer
-
Ovarian cancer
-
Endometrial cancers
-
Cervical cancer
-
and other cancers significantly impacted by female biology
Patients at the Centre
Her biology. Her voice. Her life. That’s our starting point.
Real Outcomes
Our model delivers what matters: earlier, more accurate diagnoses; fewer side effects; and treatments that acknowledge the urgency and reality of cancers affecting women.
Patient-First Model
Our number 1 priority is to get effective treatments to patients fast.
Want to get in touch?
Fill out our form and we'll get back to you shortly.
* Please note, all fields are mandatory
Prefer E-Mail? You can reach us directly at [email protected]
"*" indicates required fields